Plant Comparison

Licorice root vs Red Clover

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant
Second plant
Show:
Plant ALicorice rootGlycyrrhiza glabraFabaceaeFull monograph →
Plant BRed CloverTrifolium pratenseFabaceaeFull monograph →

At a glance

Licorice root and Red Clover: both belong to the Fabaceae family; they share 9 indicated uses (arthritis / joint pain, bronchitis, cough, …); 4 pharmacological actions in common.

Licorice rootRed Clover
Constituents32
Pharmacological actions710
Indicated uses1416
Safety notes22
Cited sources2044
Indicated uses
Only Licorice root
Acid refluxCold & fluImmune supportIndigestionInfection (general)
Shared (9)
Arthritis / joint painBronchitisCoughInflammation (general)Menstrual crampsMuscle spasmRespiratory supportSkin irritationWounds
Only Red Clover
Cardiovascular / heart healthMenopauseHot flashesHigh cholesterolCancer (anticancer research)Blood sugar / diabetes supportCognitive function
Pharmacological actions
Only Licorice root
AntiviralGastroprotectiveImmunomodulator / immune support
Shared (4)
Anti-inflammatoryAntimicrobialAntispasmodicExpectorant
Only Red Clover
AntioxidantLipid-loweringAnticancer (preclinical)Neuroprotective / cognition supportAntidiabetic (blood-sugar lowering)Vulnerary (wound healing)

Evidence face-off — shared uses

ConditionLicorice rootRed CloverVerdict
Arthritis / joint pain1/105/10Stronger for Red Clover
Bronchitis1/105/10Stronger for Red Clover
Cough1/105/10Stronger for Red Clover
Inflammation (general)1/105/10Stronger for Red Clover
Menstrual cramps1/105/10Stronger for Red Clover
Muscle spasm1/105/10Stronger for Red Clover
Respiratory support1/105/10Stronger for Red Clover
Skin irritation1/105/10Stronger for Red Clover
Wounds1/107/10Stronger for Red Clover

Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.

Key Constituents

Triterpenoid saponins (glycyrrhizin/glycyrrhizic acid)[1]

The principal sweet-tasting compound, about 50 times sweeter than sucrose; responsible for the anti-inflammatory, antiviral and gastroprotective activity and also for the pseudoaldosteronism risk on prolonged high-dose use.

SaponinsGlycyrrhizin
Flavonoids and isoflavones (liquiritin, glabridin)[1]

Antioxidant and antimicrobial polyphenols, including the skin-lightening compound glabridin.

Flavonoids
Coumarins and sterols[1]

Minor supporting constituents of the root.

Isoflavones (formononetin, biochanin A, daidzein, genistein)[14]

Phytoestrogenic isoflavones responsible for the plant's estrogenic and cardiovascular research interest; one of the richest known plant sources.

Flavonoids
Coumarins[40]

Contribute mild anticoagulant activity; relevant to the plant's caution around blood-thinning medication.

Coumarins

Pharmacological Actions

Anti-inflammatory[1, 3, 4, 9, 11, 13, 14, 15]
Antimicrobial[8, 13, 14, 15]
Antispasmodic[13, 14, 15]

Antispasmodic (cramp easing)

Antiviral[13, 14, 15]
Expectorant[13, 14, 15]
Gastroprotective[13, 14, 15]
Immunomodulator / immune support[13, 14, 15]
Anti-inflammatory[4, 14, 17, 22, 28, 33, 34, 40, 41]
Antioxidant[4, 6, 14, 16, 17, 22, 28, 29, 40, 41]
Antispasmodic[8, 14, 40, 41]

Antispasmodic (cramp easing)

Expectorant[14, 40, 41]
Lipid-lowering[5, 11, 13]
Anticancer (preclinical)[16, 18, 19, 20, 21, 35, 36, 37]
Neuroprotective / cognition support[23, 30, 31, 32]
Antidiabetic (blood-sugar lowering)[24, 25, 38]
Antimicrobial[17, 27]
Vulnerary (wound healing)[17, 39]

Traditional & Indicated Uses

Acid reflux[13, 14, 15]Traditional · 1/10

inferred from gastroprotective action

Evidence: 1
Label: Acid reflux
Arthritis / joint pain[13, 14, 15]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Bronchitis[13, 14, 15]Traditional · 1/10

inferred from expectorant action

Evidence: 1
Label: Bronchitis
Cold & flu[13, 14, 15]Traditional · 1/10

inferred from antiviral action

Evidence: 1
Label: Cold & flu
Cough[13, 14, 15]Traditional · 1/10

inferred from expectorant action

Evidence: 1
Label: Cough
Immune support[13, 14, 15]Traditional · 1/10
Evidence: 1
Label: Immune support
Indigestion[13, 14, 15]Traditional · 1/10

inferred from gastroprotective action

Evidence: 1
Label: Indigestion
Infection (general)[13, 14, 15]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Infection (general)
Inflammation (general)[13, 14, 15]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Inflammation (general)
Menstrual cramps[13, 14, 15]Traditional · 1/10

inferred from antispasmodic action

Evidence: 1
Label: Menstrual cramps
Muscle spasm[13, 14, 15]Traditional · 1/10

inferred from antispasmodic action

Evidence: 1
Label: Muscle spasm
Respiratory support[13, 14, 15]Traditional · 1/10

inferred from expectorant action

Evidence: 1
Label: Respiratory support
Skin irritation[13, 14, 15]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Skin irritation
Wounds[13, 14, 15]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Wounds
Arthritis / joint pain[14, 34, 40, 41]Moderate · 5/10

inferred from anti-inflammatory action

Evidence: 5
Label: Arthritis / joint pain
Bronchitis[14, 40, 41]Moderate · 5/10

inferred from expectorant action

Evidence: 5
Label: Bronchitis
Cardiovascular / heart health[2, 10, 13, 14, 16, 33, 40, 41]Strong · 9/10
Evidence: 9
Label: Cardiovascular / heart health
Cough[14, 40, 41]Moderate · 5/10

inferred from expectorant action

Evidence: 5
Label: Cough
Inflammation (general)[14, 28, 40, 41]Moderate · 5/10

inferred from anti-inflammatory action

Evidence: 5
Label: Inflammation (general)
Menstrual cramps[8, 14, 40, 41]Moderate · 5/10
Evidence: 5
Label: Menstrual cramps
Muscle spasm[8, 14, 40, 41]Moderate · 5/10

inferred from antispasmodic action

Evidence: 5
Label: Muscle spasm
Respiratory support[14, 40, 41]Moderate · 5/10

inferred from expectorant action

Evidence: 5
Label: Respiratory support
Skin irritation[7, 14, 40, 41]Moderate · 5/10

inferred from anti-inflammatory action

Evidence: 5
Label: Skin irritation
Menopause[1, 5, 11, 12, 15]Strong · 9/10
Evidence: 9
Label: Menopause
Hot flashes[1, 5, 11, 12]Strong · 9/10
Evidence: 9
Label: Hot flashes
High cholesterol[5, 11, 13]Strong · 9/10
Evidence: 9
Label: High cholesterol
Cancer (anticancer research)[16, 18, 19, 20, 21, 35, 36, 37]Good · 7/10

inferred from anticancer action

Evidence: 7
Label: Cancer (anticancer research)
Blood sugar / diabetes support[24, 25, 38]Traditional · 2/10
Evidence: 2
Label: Blood sugar / diabetes support
Cognitive function[23, 30, 31, 32]Good · 8/10

inferred from neuroprotective action

Evidence: 8
Label: Cognitive function
Wounds[17, 39]Good · 7/10

inferred from vulnerary action

Evidence: 7
Label: Wounds

Safety, Cautions & Contraindications

Safety note[13, 14, 15]Caution

Avoid prolonged use of whole licorice root in large doses. May cause pseudoaldosteronism (hypertension, oedema, hypokalaemia). Contraindicated in hypertension, renal failure, liver disease, hypokalaemia, and pregnancy. DGL form is safer for prolonged gastric use. Interactions with antihypertensives, diuretics, and corticosteroids.

Safety note[13, 14, 15, 16]Caution

Duke (2002) rates licorice as ++ and documents extensive activities. Glycyrrhizin (the key compound) has anti-inflammatory, antiulcer, antiviral, and adrenal-stimulant properties. Duke highlights an important safety concern: chronic use of licorice can cause pseudoaldosteronism — sodium retention, potassium loss, edema, and hypertension — due to glycyrrhizin's inhibition of cortisol metabolism. This effect is typically seen with >50 g licorice/day for more than 6 weeks. Deglycyrrhizinated licorice (DGL) avoids this side effect. Dose: 5–15 g dried root daily. Contraindicated in hypertension, kidney disease, low potassium, liver cirrhosis, and in combination with diuretics or corticosteroids (Duke, 2002).

Safety note[14, 40, 41]Caution

Generally safe in normal dietary amounts. Isoflavones are phytoestrogens — exercise caution in oestrogen-receptor-positive breast cancer patients or those taking hormone therapies. May interact with warfarin (antiplatelet activity). Avoid in pregnancy and breastfeeding. Well tolerated in most adults.

Safety note[14, 40, 41, 42]Caution

Duke (2002) rates red clover as +++ and provides clinical evidence (score 2) for estrogenic activity — the plant is one of the richest plant sources of isoflavones (formononetin, biochanin A, daidzein, genistein). Clinical applications include menopausal symptom relief, osteoporosis prevention, and cardiovascular protection in peri-menopausal women. Dose: standardized extract providing 40–160 mg isoflavones daily. Duke cautions that due to strong estrogenic activity, red clover is not recommended in estrogen-dependent cancers (breast, uterine) or alongside hormone replacement therapy without medical supervision. Anti-coagulant coumarins are also present (Duke, 2002).

External Ids

Gbif: 2965732
Wikidata: Q257106
Gbif: 8324121
Wikidata: Q156635

Botanical Description

Herbaceous perennial legume with pinnately compound leaves of small, oval, slightly sticky leaflets. Pale blue-violet to lilac pea-like flowers are borne in loose spikes, followed by small, flattened, oblong pods. The sweet-tasting rhizome and root system, brownish-grey outside and bright yellow inside, is the medicinal part, spreading extensively underground via stolons.[1]

Height: 1-1.5 m
Habit: Herbaceous perennial legume, spreading by underground stolons
Leaves: Pinnately compound, small oval leaflets, slightly sticky
Flowers: Pale blue-violet to lilac, pea-like, in loose spikes
Stem: Erect, branching
Root: Extensive, sweet-tasting rhizome and root system, brownish-grey outside, bright yellow inside
Fruit: Small, flattened, oblong pod
Flowering Period: June-August

Short-lived perennial herb with trifoliate leaves, each leaflet oval and often marked with a pale chevron, arising from a spreading, slightly hairy stem. Dense, rounded, pink to magenta flower heads are borne at the stem tips.[40]

Height: 20-60 cm
Habit: Short-lived perennial herb, spreading via a branching taproot
Leaves: Trifoliate, each leaflet oval with a pale chevron marking, slightly hairy
Flowers: Dense, rounded heads of small pink to magenta pea-like flowers
Stem: Slightly hairy, branching, spreading
Root: Branching taproot with nitrogen-fixing root nodules
Fruit: Small pod containing 1-2 seeds, enclosed within the dried flower head
Flowering Period: May-September

Habitat

Grows in dry, sunny, deep-soiled sites, riverbanks and open scrub; native to the Mediterranean region and Western to Central Asia, and cultivated widely for its root.[1]

Grows in meadows, pastures, roadsides and grassy waste ground; native to Europe, western Asia and North Africa and widely naturalised and cultivated as a forage crop elsewhere.[40]

Harvesting

The root and rhizome are dug in autumn from plants at least three to four years old, when glycyrrhizin content is highest, then cleaned and dried; sold whole, cut, or as processed extract.[1]

Parts: Root
Season: Autumn, from mature (3-4+ year) plants

The flowering heads are picked at full bloom in summer and dried quickly in a warm, shaded, airy place to preserve isoflavone content and colour.[40]

Parts: Flower, Leaf
Season: Summer, at full bloom

Traditional Uses

Licorice root is one of the oldest and most widely used herbs in the world, with a documented history across Chinese, Ayurvedic, Greek and European traditional medicine as a soothing demulcent and expectorant for coughs and sore throat, a gastroprotective remedy for stomach discomfort and ulcers, and a harmonising, sweetening addition to herbal formulas.[1]

Red clover flower has a long folk tradition as a blood-purifying and expectorant remedy for coughs and skin complaints, and more recently has become one of the most studied herbal sources of isoflavone phytoestrogens, researched for menopausal symptom relief and cardiovascular and bone support.[14, 40, 41]

Preparations

Decoction[1]

Dried root simmered in water as a traditional soothing, expectorant and gastroprotective tea.

Standardised extract[1]

Root extract standardised to glycyrrhizin content, taken as capsules or lozenges.

Infusion (flower)[40]

Dried flower heads infused in hot water as a traditional tea for coughs and as a general tonic.

Standardized isoflavone extract[14]

Standardized isoflavone extract in tablet form, the form used in most menopause-related clinical research.

Dosage

Whole root/decoction[12]

The EU herbal monograph gives, for adults and elderly, 1.5-2 g of the comminuted root in 150 mL of boiling water as an infusion or decoction 2 to 4 times daily, taken one cup after meals; a soft extract (DER 1:0.4-0.5) at 32 mg 2-3 times daily, not exceeding 160 mg daily, is also listed. The monograph directs that it is NOT to be used for more than 4 weeks, and is not recommended under 18 years - the duration limit matters because prolonged licorice use causes pseudoaldosteronism (sodium and water retention, potassium loss, raised blood pressure). Deglycyrrhizinated licorice (DGL) is preferred where prolonged use is intended. Educational reference only, not a prescription.

Standardized extract[14]

Clinical research commonly uses around 40-80 mg isoflavones daily. Educational reference only, not a prescription.

References

REF-0826, REF-0827, REF-0828, REF-2187, REF-2188, REF-2189, REF-2190, REF-2191, REF-2192, REF-2193, REF-2194
REF-1104, REF-1105, REF-1106, REF-1107, REF-1108, REF-1109, REF-1110, REF-1111, REF-1112, REF-1113, REF-2344, REF-2345, REF-2346, REF-0013, REF-2347, REF-2889, REF-2890, REF-2891, REF-2892, REF-2893, REF-2894, REF-2895, REF-2896, REF-2897, REF-2898, REF-2899, REF-2900, REF-2923, REF-2924, REF-2925, REF-2926, REF-2927, REF-2928, REF-2929, REF-2930, REF-2931, REF-2932, REF-2933, REF-2934

Drug Class Interactions

Safety note[17, 18, 19, 20]Caution
Drug Class: antihypertensives
Mechanism: Licorice (glycyrrhizic acid) can cause sodium retention, potassium loss and raised blood pressure (pseudoaldosteronism), which can oppose blood-pressure medicines. Meta-analyses of randomised trials confirm that glycyrrhizic acid raises systolic and diastolic blood pressure, and a crossover trial found this even at a low daily dose (100 mg). Avoid regular or high licorice intake if you take blood-pressure medicines.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Safety note[17, 18]Caution
Drug Class: cardiac-glycosides
Mechanism: Licorice-induced potassium loss can increase the risk of digoxin toxicity; a meta-analysis confirms licorice lowers plasma potassium, and low potassium makes the heart more sensitive to cardiac glycosides. Avoid regular or high intake.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Safety note[18]Caution
Drug Class: diuretics
Mechanism: Licorice (glycyrrhizic acid) causes the body to lose potassium; combined with potassium-wasting water tablets (thiazide or loop diuretics such as hydrochlorothiazide or furosemide) this can add up to dangerously low potassium, which a meta-analysis confirms licorice lowers. Licorice also works against potassium-sparing diuretics such as spironolactone by mimicking aldosterone. Avoid regular or high licorice intake with any diuretic.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Safety note[43, 44]Caution
Drug Class: hormonal-therapies
Mechanism: Red clover is rich in isoflavones that act like weak oestrogens; its safety alongside hormone medicines (such as the contraceptive pill, HRT, or breast-cancer hormone treatments like tamoxifen) or in hormone-sensitive conditions is not established, so combined use warrants caution and medical advice.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03

Lookalikes Review

Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07

References & Sources

  1. Pastorino, G., Cornara, L., Soares, S., Rodrigues, F. and Oliveira, M.B.P.P (2018) 'Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review', Phytotherapy Research, 32(12), pp. 2323-2339. doi:10.1002/ptr.6178 Traditional / reference
    https://doi.org/10.1002/ptr.6178
  2. Nazari, S., Rameshrad, M. and Hosseinzadeh, H (2017) 'Toxicological Effects of Glycyrrhiza glabra (Licorice): A Review', Phytotherapy Research, 31(11), pp. 1635-1650. doi:10.1002/ptr.5893 Traditional / reference
    https://doi.org/10.1002/ptr.5893
  3. El-Saber Batiha, G., Magdy Beshbishy, A., El-Mleeh, A., Abdel-Daim, M.M. and Prasad Devkota, H (2020) 'Traditional Uses, Bioactive Chemical Constituents, and Pharmacological and Toxicological Activities of Glycyrrhiza glabra L. (Fabaceae)', Biomolecules, 10(3), pp. 352. doi:10.3390/biom10030352 Traditional / reference
    https://doi.org/10.3390/biom10030352
  4. Wahab, S., Annadurai, S., Abullais, S.S., Das, G., Ahmad, W., Ahmad, M.F., Kandasamy, G., Vasudevan, R., Ali, M.S. and Amir, M (2021) 'Glycyrrhiza glabra (licorice): a comprehensive review on its phytochemistry, biological activities, clinical evidence and toxicology', Plants, 10(12), pp. 2751. doi:10.3390/plants10122751 Meta-analysis / review
    https://doi.org/10.3390/plants10122751
  5. Markina, Y.V., Kirichenko, T.V., Markin, A.M., Yudina, I.Y., Starodubova, A.V., Sobenin, I.A. and Orekhov, A.N (2022) 'Atheroprotective effects of Glycyrrhiza glabra L', Molecules, 27(15), pp. 4697. doi:10.3390/molecules27154697 Meta-analysis / review
    https://doi.org/10.3390/molecules27154697
  6. Jafari, F., Jafari, M., Moghadam, A.T., Emami, S.A., Jamialahmadi, T., Mohammadpour, A.H. and Sahebkar, A (2021) 'A review of Glycyrrhiza glabra (licorice) effects on metabolic syndrome', Advances in Experimental Medicine and Biology, 1328, pp. 385-400. doi:10.1007/978-3-030-73234-9_25 Meta-analysis / review
    https://doi.org/10.1007/978-3-030-73234-9_25
  7. Schmid, C., Dawid, C., Peters, V. and Hofmann, T (2018) 'Saponins from European licorice roots (Glycyrrhiza glabra)', Journal of Natural Products, 81(8), pp. 1734-1744. doi:10.1021/acs.jnatprod.8b00022 Preclinical
    https://doi.org/10.1021/acs.jnatprod.8b00022
  8. Kalani, K., Chaturvedi, V., Alam, S., Khan, F. and Srivastava, S.K (2015) 'Anti-tubercular agents from Glycyrrhiza glabra', Current Topics in Medicinal Chemistry, 15(11), pp. 1043-1049. doi:10.2174/1568026615666150317223323 Preclinical
    https://doi.org/10.2174/1568026615666150317223323
  9. Frattaruolo, L., Carullo, G., Brindisi, M., Mazzotta, S., Bellissimo, L., Rago, V., Curcio, R., Dolce, V., Aiello, F. and Cappello, A.R (2019) 'Antioxidant and anti-inflammatory activities of flavanones from Glycyrrhiza glabra L. (licorice) leaf phytocomplexes: identification of licoflavanone as a modulator of NF-kB/MAPK pathway', Antioxidants, 8(6), pp. 186. doi:10.3390/antiox8060186 Preclinical
    https://doi.org/10.3390/antiox8060186
  10. Eltahir, A.O.E., Omoruyi, S.I., Augustine, T.N., Luckay, R.C. and Hussein, A.A (2024) 'Neuroprotective effects of Glycyrrhiza glabra total extract and isolated compounds', Pharmaceuticals, 17(7), pp. 852. doi:10.3390/ph17070852 Preclinical
    https://doi.org/10.3390/ph17070852
  11. Dastagir, G. and Rizvi, M.A (2016) 'Review - Glycyrrhiza glabra L. (liquorice)', Pakistan Journal of Pharmaceutical Sciences, 29(5), pp. 1727-1733. Meta-analysis / review
    https://scholar.google.com/scholar?q=Review%20-%20Glycyrrhiza%20glabra%20L.%20%28liquorice%29
  12. European Medicines Agency (HMPC) (2013) 'Community herbal monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf Traditional / reference
    https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
  13. Asl, M.N. and Hosseinzadeh, H (2008) 'Review of pharmacological effects of Glycyrrhiza sp', 22(6), pp. 709--724. Traditional / reference
    https://scholar.google.com/scholar?q=Review%20of%20pharmacological%20effects%20of%20Glycyrrhiza%20sp.
  14. Fiore, C. et al (2008) 'A history of the therapeutic use of liquorice in Europe', 99(3), pp. 317--324. doi:10.1016/j.jep.2005.04.015 Traditional / reference
    https://doi.org/10.1016/j.jep.2005.04.015
  15. WHO (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
    https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants
  16. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
  17. Takahashi, K., Yoshino, T., Maki, Y., Ishiuchi, K., Namiki, T., Ogawa-Ochiai, K., Minamizawa, K., Makino, T., Nakamura, T., Mimura, M. and Watanabe, K (2019) 'Identification of glycyrrhizin metabolites in humans and of a potential biomarker of liquorice-induced pseudoaldosteronism', Archives of Toxicology, 93(11), pp. 3111-3119. doi:10.1007/s00204-019-02588-2 Clinical study
    https://doi.org/10.1007/s00204-019-02588-2
  18. Penninkilampi, R., Eslick, E.M. and Eslick, G.D (2017) 'The association between consistent licorice ingestion, hypertension and hypokalaemia: a systematic review and meta-analysis', Journal of Human Hypertension, 31(11), pp. 699-707. doi:10.1038/jhh.2017.45 Meta-analysis / review
    https://doi.org/10.1038/jhh.2017.45
  19. Wu, T., Yang, J., Xia, J. and Sun, G (2024) 'Effects of licorice functional components intakes on blood pressure: a systematic review with meta-analysis and network toxicology', Nutrients, 16(21), pp. 3768. doi:10.3390/nu16213768 Meta-analysis / review
    https://doi.org/10.3390/nu16213768
  20. af Geijerstam, P., Joelsson, A., Radholm, K. and Nystrom, F.H (2024) 'A low dose of daily licorice intake affects renin, aldosterone, and home blood pressure in a randomized crossover trial', The American Journal of Clinical Nutrition, 119(3), pp. 682-691. doi:10.1016/j.ajcnut.2024.01.011 Randomized trial
    https://doi.org/10.1016/j.ajcnut.2024.01.011
  1. Kanadys, W., Baranska, A., Blaszczuk, A., Polz-Dacewicz, M. and others (2021) 'Evaluation of Clinical Meaningfulness of Red Clover (Trifolium pratense L.) Extract to Relieve Hot Flushes and Menopausal Symptoms in Peri- and Post-Menopausal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials', Nutrients, 13(4), pp. 1258. doi:10.3390/nu13041258 Meta-analysis / review
    https://doi.org/10.3390/nu13041258
  2. Kanadys, W., Baranska, A., Jedrych, M., Religioni, U. and others (2019) 'Effects of red clover (Trifolium pratense) isoflavones on the lipid profile of perimenopausal and postmenopausal women-A systematic review and meta-analysis', Maturitas, 132, pp. 7-16. doi:10.1016/j.maturitas.2019.11.001 Meta-analysis / review
    https://doi.org/10.1016/j.maturitas.2019.11.001
  3. Yokoyama, S.I., Kodera, M., Hirai, A., Nakada, M. and others (2020) 'Red Clover (Trifolium pratense L.) Sprout Prevents Metabolic Syndrome', Journal of Nutritional Science and Vitaminology, 66(1), pp. 48-53. doi:10.3177/jnsv.66.48 Preclinical
    https://doi.org/10.3177/jnsv.66.48
  4. Gosciniak, A., Szulc, P., Zielewicz, W., Walkowiak, J. and others (2023) 'Multidirectional Effects of Red Clover (Trifolium pratense L.) in Support of Menopause Therapy', Molecules, 28(13), pp. 5178. doi:10.3390/molecules28135178 Meta-analysis / review
    https://doi.org/10.3390/molecules28135178
  5. Booth, N.L., Piersen, C.E., Banuvar, S., Geller, S.E. and others (2006) 'Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: a literature review', Menopause, 13(2), pp. 251-264. doi:10.1097/01.gme.0000198297.40269.f7 Meta-analysis / review
    https://doi.org/10.1097/01.gme.0000198297.40269.f7
  6. Oza, M.J. and Kulkarni, Y.A (2020) 'Trifolium pratense (Red Clover) Improves SIRT1 Expression and Glycogen Content in High Fat Diet-Streptozotocin Induced Type 2 Diabetes in Rats', Chemistry & Biodiversity, 17(4), pp. e2000019. doi:10.1002/cbdv.202000019 Preclinical
    https://doi.org/10.1002/cbdv.202000019
  7. Circosta, C., De Pasquale, R., Palumbo, D.R., Samperi, S. and others (2006) 'Effects of isoflavones from red clover (Trifolium pratense) on skin changes induced by ovariectomy in rats', Phytotherapy Research, 20(12), pp. 1096-1099. doi:10.1002/ptr.2017 Preclinical
    https://doi.org/10.1002/ptr.2017
  8. Brandli, A., Simpson, J.S. and Ventura, S (2010) 'Isoflavones isolated from red clover (Trifolium pratense) inhibit smooth muscle contraction of the isolated rat prostate gland', Phytomedicine, 17(11), pp. 895-901. doi:10.1016/j.phymed.2010.05.006 Preclinical
    https://doi.org/10.1016/j.phymed.2010.05.006
  9. Burdette, J.E., Liu, J., Lantvit, D., Lim, E. and others (2002) 'Trifolium pratense (red clover) exhibits estrogenic effects in vivo in ovariectomized Sprague-Dawley rats', The Journal of Nutrition, 132(1), pp. 27-30. doi:10.1093/jn/132.1.27 Preclinical
    https://doi.org/10.1093/jn/132.1.27
  10. Jiang, Y.B. and Yang, Y.R (2016) 'Trifolium pratense isoflavones improve pulmonary vascular remodelling in broiler chickens', Journal of Animal Physiology and Animal Nutrition, 100(6), pp. 1159-1168. doi:10.1111/jpn.12424 Preclinical
    https://doi.org/10.1111/jpn.12424
  11. Yigit, E. and Unsal, S (2024) 'Isoflavones obtained from red clover improve both dyslipidemia and menopausal symptoms in menopausal women: a prospective randomized placebo-controlled trial', Climacteric, 27(6), pp. 548-554. doi:10.1080/13697137.2024.2393121 Randomized trial
    https://doi.org/10.1080/13697137.2024.2393121
  12. Lethaby, A.E., Brown, J., Marjoribanks, J., Kronenberg, F., Roberts, H. and Eden, J (2007) 'Phytoestrogens for vasomotor menopausal symptoms', Cochrane Database of Systematic Reviews, (4), pp. CD001395. doi:10.1002/14651858.CD001395.pub3 Meta-analysis / review
    https://doi.org/10.1002/14651858.CD001395.pub3
  13. Geller, S.E. and Studee, L (2006) 'Soy and red clover for mid-life and aging', Climacteric, 9(4), pp. 245-263. doi:10.1080/13697130600736934 Meta-analysis / review
    https://doi.org/10.1080/13697130600736934
  14. Atkinson, C. et al (2004) 'The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial', 79(2), pp. 326--333. doi:10.1093/ajcn/79.2.326 Randomized trial
    https://doi.org/10.1093/ajcn/79.2.326
  15. Quah, Y., Yi-Le, J.C., Park, N.H., Lee, Y.Y., Lee, E.B., Jang, S.H., Kim, M.J., Rhee, M.H., Lee, S.J. and Park, S.C (2022) 'Serum biomarker-based osteoporosis risk prediction and the systemic effects of Trifolium pratense ethanolic extract in a postmenopausal model', Chinese Medicine, 17(1), pp. 70. doi:10.1186/s13020-022-00622-7 Preclinical
    https://doi.org/10.1186/s13020-022-00622-7
  16. Mohsen, A. and Fatemeh, K. and Leila, N. and Mona, P. and Mohammad, Z. and Mozafar, K (2021) 'Pharmacological and therapeutic properties of the Red Clover (Trifolium pratense L.): an overview of the new finding', J Tradit Chin Med, 41(4), pp. 642-649. doi:10.19852/j.cnki.jtcm.20210324.001 Meta-analysis / review
    https://doi.org/10.19852/j.cnki.jtcm.20210324.001
  17. Antonescu Mintas, A.I. and Miere Groza, F. and Fritea, L. and Ganea, M. and Zdrinca, M. and Dobjanschi, L. and Antonescu, A. and Vicas, S.I. and Bodog, F. and Sindhu, R.K. and Cavalu, S (2021) 'Perspectives on the Combined Effects of Trifolium pratense and Ocimum basilicum Extracts in Terms of Phytochemical Profile and Pharmacological Effects', Plants (Basel), 10(7). doi:10.3390/plants10071390 Meta-analysis / review
    https://doi.org/10.3390/plants10071390
  18. Tanrıverdi, G. and Abdulova, A. and Çölgeçen, H. and Atar, H. and Kaleci, B. and Ekiz-Yılmaz, T (2023) 'Investigation of apoptotic and antiproliferative effects of Turkish natural tetraploid Trifolium pratense L. extract on C6 glioblastoma cells via light and electron microscopy', Ultrastruct Pathol, 47(3), pp. 160-171. doi:10.1080/01913123.2023.2184893 Preclinical
    https://doi.org/10.1080/01913123.2023.2184893
  19. Zakłos-Szyda, M. and Budryn, G (2020) 'The Effects of Trifolium pratense L. Sprouts' Phenolic Compounds on Cell Growth and Migration of MDA-MB-231, MCF-7 and HUVEC Cells', Nutrients, 12(1). doi:10.3390/nu12010257 Preclinical
    https://doi.org/10.3390/nu12010257
  20. Khazayel, S. and Faraji, M.H. and Akbaribazm, M. and Khazaei, M. and Niromand, E. and Khazaei, M.R (2025) 'Synergistic inhibitory effects of Trifolium pratense L. extract and doxorubicin on 4T1 tumor-bearing mice are mediated via targeting the Wnt/beta-catenin pathway and reversal of epithelial-mesenchymal transition', Avicenna J Phytomed, 15(5), pp. 1546-1561. doi:10.22038/ajp.2025.25940 Preclinical
    https://doi.org/10.22038/ajp.2025.25940
  21. Shirani Asl, V. and Rafieemehr, H. and Tamaddon, G (2024) 'The impact of Trifolium pratense extract on apoptosis and autophagy in NALM-6 cells: implications for B-ALL intervention', Med Oncol, 41(11), pp. 257. doi:10.1007/s12032-024-02485-4 Preclinical
    https://doi.org/10.1007/s12032-024-02485-4
  22. Won, J.P. and Kim, E. and Hur, J. and Lee, H.G. and Lee, W.J. and Seo, H.G (2023) 'Red clover (Trifolium pratense L.) extract inhibits ferroptotic cell death by modulating cellular iron homeostasis', J Ethnopharmacol, 308, pp. 116267. doi:10.1016/j.jep.2023.116267 Preclinical
    https://doi.org/10.1016/j.jep.2023.116267
  23. Al-Shami, A.S. and Essawy, A.E. and Elkader, H.A.E.A (2023) 'Molecular mechanisms underlying the potential neuroprotective effects of Trifolium pratense and its phytoestrogen-isoflavones in neurodegenerative disorders', Phytother Res, 37(6), pp. 2693-2737. doi:10.1002/ptr.7870 Meta-analysis / review
    https://doi.org/10.1002/ptr.7870
  24. Zhang, H. and Zhao, J. and Shang, H. and Guo, Y. and Chen, S (2020) 'Extraction, purification, hypoglycemic and antioxidant activities of red clover (Trifolium pratense L.) polysaccharides', Int J Biol Macromol, 148, pp. 750-760. doi:10.1016/j.ijbiomac.2020.01.194 Preclinical
    https://doi.org/10.1016/j.ijbiomac.2020.01.194
  25. Khazaei, A.H. and Bozorgi, A. and Ghanbari, E. and Bozorgi, M. and Khazaei, M (2025) 'Trifolium pratense-Derived Exosome Improved Serum Biochemical Parameters and Pancreatic Genes in STZ-Induced Diabetic Rats', Endocrinol Diabetes Metab, 8(5), pp. e70103. doi:10.1002/edm2.70103 Preclinical
    https://doi.org/10.1002/edm2.70103
  26. Hitzman, R. and Malca-Garcia, G.R. and Howell, C. and Park, H.Y. and Friesen, J.B. and Dong, H. and Dunlap, T. and McAlpine, J.B. and Vollmer, G. and Bosland, M.C. and Nikolić, D. and Lankin, D.C. and Chen, S.N. and Bolton, J.L. and Pauli, G.F. and Dietz, B.M (2023) 'DESIGNER fraction concept unmasks minor bioactive constituents in red clover (Trifolium pratense L.)', Phytochemistry, 214, pp. 113789. doi:10.1016/j.phytochem.2023.113789 Preclinical
    https://doi.org/10.1016/j.phytochem.2023.113789
  27. Lien, Y.Y. and Shyur, L.F. and Cheng, Y.B. and Chang, M.T. and Chang, C.T. and Chen, Y.H. and Lai, G.H. and Liao, H.Y. and Cheng, M.C (2024) 'Trifolium pratense as a novel phytogenic supplement, is an anticoccidial agent in chickens', Poult Sci, 103(10), pp. 104064. doi:10.1016/j.psj.2024.104064 Preclinical
    https://doi.org/10.1016/j.psj.2024.104064
  28. Lee, S.G. and Brownmiller, C. and Lee, S. and Kang, H.W (2020) 'Anti-Inflammatory and Antioxidant Effects of Anthocyanins of Trifolium pratense (Red Clover) in Lipopolysaccharide-Stimulated RAW-267.4 Macrophages', Nutrients, 12(4), pp. 1089-1089. doi:10.3390/nu12041089 Preclinical
    https://doi.org/10.3390/nu12041089
  29. Akbaribazm, M. and Khazaei, M.R. and Khazaei, M.R. and Khazaei, M. and Khazaei, M (2020) 'Phytochemicals and antioxidant activity of alcoholic/hydroalcoholic extract of Trifolium pratense', Chinese Herbal Medicines, 12(3), pp. 326-335. doi:10.1016/j.chmed.2020.02.002 Preclinical
    https://doi.org/10.1016/j.chmed.2020.02.002
  30. Fu, X. and Qin, T. and Yu, J. and Jiao, J. and Ma, Z. and Fu, Q. and Deng, X. and Ma, S (2019) 'Formononetin Ameliorates Cognitive Disorder via PGC-1α Pathway in Neuroinflammation Conditions in High-Fat Diet-Induced Mice', CNS & Neurological Disorders - Drug Targets, 18(7), pp. 566-577. doi:10.2174/1871527318666190807160137 Preclinical
    https://doi.org/10.2174/1871527318666190807160137
  31. Singh, L. and Kaur, H. and Arya, G.C. and Bhatti, R (2023) 'Neuroprotective potential of formononetin, a naturally occurring isoflavone phytoestrogen', Chemical Biology & Drug Design, 103(1), pp. e14353-e14353. doi:10.1111/cbdd.14353 Meta-analysis / review
    https://doi.org/10.1111/cbdd.14353
  32. Tan, J.W. and Kim, M (2016) 'Neuroprotective Effects of Biochanin A against β-Amyloid-Induced Neurotoxicity in PC12 Cells via a Mitochondrial-Dependent Apoptosis Pathway', Molecules, 21(5), pp. 548-548. doi:10.3390/molecules21050548 Preclinical
    https://doi.org/10.3390/molecules21050548
  33. Bai, Y. and Li, Z. and Liu, W. and Gao, D. and Liu, M. and Zhang, P (2019) 'Biochanin A attenuates myocardial ischemia/reperfusion injury through the TLR4/NF-κB/NLRP3 signaling pathway', Acta Cirúrgica Brasileira, 34(11), pp. e201901104-e201901104. doi:10.1590/s0102-865020190110000004 Preclinical
    https://doi.org/10.1590/s0102-865020190110000004
  34. Félix, F.B. and Vago, J.P. and Fernandes, D.D.O. and Martins, D.G. and Zaidan, I. and Gonçalves, W.A. and Costa, W.C. and Araújo, J.M.D. and Queiroz‐Junior, C.M. and Campolina-Silva, G.H. and Soriani, F.M. and Sousa, L.P. and Grespan, R. and Teixeira, M.M. and Pinho, V (2021) 'Biochanin A Regulates Key Steps of Inflammation Resolution in a Model of Antigen-Induced Arthritis via GPR30/PKA-Dependent Mechanism', Frontiers in Pharmacology, 12, pp. 662308-662308. doi:10.3389/fphar.2021.662308 Preclinical
    https://doi.org/10.3389/fphar.2021.662308
  35. Akbaribazm, M. and Khazaei, M.R. and Khazaei, M.R. and Khazaei, M. and Khazaei, M (2020) 'Trifolium pratense L. (red clover) extract and doxorubicin synergistically inhibits proliferation of 4T1 breast cancer in tumor‐bearing BALB/c mice through modulation of apoptosis and increase antioxidant and anti‐inflammatory related pathways', Food Science & Nutrition, 8(8), pp. 4276-4290. doi:10.1002/fsn3.1724 Preclinical
    https://doi.org/10.1002/fsn3.1724
  36. Akbaribazm, M. and Khazaei, M.R. and Khazaei, M.R. and Khazaei, F. and Khazaei, M. and Khazaei, M (2020) 'Doxorubicin and Trifolium pratense L. (Red clover) extract synergistically inhibits brain and lung metastases in 4T1 tumor‐bearing BALB/c mice', Food Science & Nutrition, 8(10), pp. 5557-5570. doi:10.1002/fsn3.1820 Preclinical
    https://doi.org/10.1002/fsn3.1820
  37. Khazaei, M. and Pazhouhi, M (2018) 'Antiproliferative Effect of Trifolium Pratens L. Extract in Human Breast Cancer Cells', Nutrition and Cancer, 71(1), pp. 128-140. doi:10.1080/01635581.2018.1521443 Preclinical
    https://doi.org/10.1080/01635581.2018.1521443
  38. Pazhouhi, M. and Khazaei, M (2018) 'Protective effect of hydroalcoholic extracts of Trifolium pratense L. on pancreatic β cell line (RIN-5F) against cytotoxicty of streptozotocin', Research in Pharmaceutical Sciences, 13(4), pp. 324-324. doi:10.4103/1735-5362.235159 Preclinical
    https://doi.org/10.4103/1735-5362.235159
  39. Antonescu, I.A. and Antonescu, A. and Miere, F. and Fritea, L. and Teușdea, A.C. and Vicaș, L.G. and Vicaş, S.I. and Brihan, I. and Domuța, M. and Zdrîncă, M. and Zdrîncă, M. and Cavalu, S (2021) 'Evaluation of Wound Healing Potential of Novel Hydrogel Based on Ocimum basilicum and Trifolium pratense Extracts', Processes, 9(11), pp. 2096-2096. doi:10.3390/pr9112096 Preclinical
    https://doi.org/10.3390/pr9112096
  40. British Herbal Medicine Association (1996) 'British Herbal Pharmacopoeia'. Traditional / reference
    https://scholar.google.com/scholar?q=British%20Herbal%20Pharmacopoeia
  41. Hoffmann, D (2003) 'Medical Herbalism'. Traditional / reference
    https://scholar.google.com/scholar?q=Medical%20Herbalism
  42. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
  43. Booth, N.L., Piersen, C.E., Banuvar, S., Geller, S.E., Shulman, L.P. and Farnsworth, N.R (2006) 'Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: a literature review', Menopause, 13(2), pp. 251-264. doi:10.1097/01.gme.0000198297.40269.f7 Meta-analysis / review
    https://doi.org/10.1097/01.gme.0000198297.40269.f7
  44. Fritz, H., Seely, D., Flower, G., Skidmore, B., Fernandes, R., Vadeboncoeur, S., Kennedy, D., Cooley, K., Wong, R., Sagar, S., Sabri, E. and Fergusson, D (2013) 'Soy, red clover, and isoflavones and breast cancer: a systematic review', PLoS One, 8(11), pp. e81968. doi:10.1371/journal.pone.0081968 Meta-analysis / review
    https://doi.org/10.1371/journal.pone.0081968

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.